J Korean Ophthalmol Soc.  2008 Mar;49(3):525-530. 10.3341/jkos.2008.49.3.525.

Perfluoro-N-octane as Postoperative Vitreous Substitutes in Retinal Detachment: A Case Report

• Chang YS
• Ghil HK
• Kim CG

• KMID: 2211330
• DOI: http://doi.org/10.3341/jkos.2008.49.3.525

Abstract

PURPOSE: To report a case of retinal detachment with a giant retinal tear, which was treated with perfluorocarbon liquid as an intraocular substitute.
CASE SUMMARY
A 37-year-old woman with a dislocated lens and a giant retinal tear underwent vitrectomy and lensectomy and was instructed to maintain a supine position after the operation. Perfluorocarbon liquid (Perfluoro-N-octane, C8F18) was used as a substitute in the vitreous cavity for 17 days. After 17 days, the perfluorocarbon liquid was removed and intraocular lens scleral fixation was performed. After removal of the perfluorocarbon liquid, the corneal endothelium was stable without other complications (including corneal edema, elevated intraocular pressure, ocular hypotony, macular pucker), and the best corrected visual acuity after intraocular lens scleral fixation was 0.4. CONCLUSIONS: Perfluorocarbon liquid is a useful surgical material in patients with a dislocated lens and retinal detachment with a giant retinal tear who have difficulty maintaining a prone position.

Keyword

Giant retinal tear; Lens dislocation; Perfluorocarbon liquid; Retinal detachment

MeSH Terms

Adult
Corneal Edema
Endothelium, Corneal
Female
Fluorocarbons
Humans
Intraocular Pressure
Lens Subluxation
Lenses, Intraocular
Ocular Hypotension
Prone Position
Retinal Detachment
Retinal Perforations
Retinaldehyde
Supine Position
Visual Acuity
Vitrectomy
Fluorocarbons
Retinaldehyde

Figure

• 

  Figure 1. Specular microscopy. (A=preoperative; B=POD #1; C=POD #5; D=POD 1 month)* POD=postoperative day after IOL scleral fixation.

• 

  Figure 2. Fundoscopic feature. (A=POD #1; B=POD 3 month)* POD=postoperative day after IOL scleral fixation.

• 

  Figure 3. Optical coherence tomography finding after intraocular lens scleral fixation (1 month postoperatively).

Reference

References

1. Scott IU, Murray TG, Flynn HW, et al. Perfluoron Study Group: Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmolgy. 2002; 109:1823–33.

2. Kertes PJ, Wafapoor H, Peyman GA, et al. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group. Ophthalmology. 1997; 104:1159–65.

3. Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Fed Proc. 1970; 20:1669–703.

4. Ryan SJ. Perfluorocarbon liquids in vitreoretinal surgery. Stanley C, Robert CK, editors. Retina. 4th ed.Baltimore: Mosby, Elsevier Inc.;2006. 3:chap. 128.

5. Chang S, Sparrow JR, Iwamoto T, et al. Experimental studies of tolerance to intravitreal perfluoro-N-octane liquid. Retina. 1991; 11:367–74.

6. Bottoni F, Sborgia M, Arpa P, et al. Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1993; 231:619–28.

7. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol. 1998; 106:668–74.

8. Lee BJ, Oum BS. Experimental studies on the retinal responses to intravitreal perfluorocarbon liquids. J Korean Ophthalmol Soc. 1998; 39:930–8.

9. Han DP, Nanda SK, O'Brien W, et al. Evaluation of anterior segment tolerance to short-term intravitreal perfluoron. Retina. 1994; 14:219–24.

10. Yang HS, Kim SD. Long-term intravitreal tamponade with perfluorophenanthrene liquid in the treatment of complicated retinal detachment. J Korean Ophthalmol Soc. 1994; 35:935–41.

11. Viebahn M, Buettner H. Perfluorophenanthrene unsuitable for postoperative retinal tamponade. Am J Ophthalmol. 1994; 118:124–6.

12. Chang S, Lincoff H, Zimmerman NJ, Fuchs W. Giant retinal tears-surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol. 1989; 107:761–6.

13. Greve MD, Peyman GA, Mehta NJ, Millsap CM. Use of perfluoroperhydrophenanthrene in the management of posteriorly dislocated crystalline and intraocular lenses. Ophthalmic Surg. 1993; 24:593–7.

14. Kreiger AE, Lewis H. Management of giant retinal tears without scleral buckling-use of radical dissection of the vitreous base and perfluorooctane and intraocular tamponade. Ophthalmology. 1989; 99:291–7.

15. Lee JE, Oum BS. Clinical evaluation of perfluorocarbon liquid in retinal detachment surgery. J Korean Ophthalmol Soc. 2000; 41:103–11.

16. Sirimaharaj M, Balachandran C, Chan WC. Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. Br J Ophthalmol. 2005; 89:1176–9.

17. Imamura Y, Minami M, Ueki M, et al. Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy. Br J Ophthalmol. 2003; 87:563–6.

18. Chang S, Reppucci V, Zimmerman NJ, et al. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology. 1989; 96:785–92.

19. Nishimura A, Kita K, Segawa Y, Shiaro Y. Perfluorocarbon liquid assists in stripping the ILM to treat detached retina caused by macular hole. Ophthalmic Surg Lasers. 2002; 33:77–8.

20. Eckardt C, Nicolai U, Winter M, Knop E. Experimental intraocular tolerance to liquid perfluorooctane and perfluoro-polyether. Retina. 1991; 11:375–84.

21. Berglin L, Ren J, Algvere PV. Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 1993; 231:233–7.

22. Velikay M, Wedrich A, Stolba U, et al. Experimental long-term vitreous replacement with purified and non-purified perfluorodecalin. Am J Ophthalmol. 1993; 116:565–70.

23. Lee MA, Kim JM, Kwak HW. A study on the corneal toxicity of perfluorocarbon liquid in the rabbit eye. J Korean Ophthalmol Soc. 1995; 36:1105–10.

24. Peyman GA, Schulman JA, Sullivan B. Perfluorocarbon liquids in ophthalmology. Surv Ophthalmol. 1995; 39:375–95.

25. Lee JR, Oum BS. Experimental studies on the retinal response to subretinal perfluorocarbon liquids. J Korean Ophthalmol Soc. 1996; 37:1443–52.